48
Growth Score
pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1960533
MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products.
Thomas Ichim: President & CSOPast Role: Therapeutic Solutions International, Director
About the Company
MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products. The company currently has 16 families of patent applications, Numerous scientific publications, and has out-licensed certain technologies to generate revenue. Medistem’s main candidate, the Endometrial Regenerative Cell is a universal
donor pluripotent stem cell, currently being developed for an advanced form of peripheral artery disease called critical limb ischemia.
